Elevance Health Inc (ELV · NYSE)
ELV · MARKET VIEW
Market view · as of Sep 28, 2026
Revenue (TTM)
$201.11B
+1.4% YoY
Gross margin
26.0%
EPS (latest q)
$7.45
vs $6.18 est · beat
52-wk position
80.5%
-6.8% vs 52w high · -0.3% 1mo
Price (last ~year)
Elevance Health (ELV, $396.09) has beaten estimates in all four of its most recent quarters, including Q2 2026 EPS of $7.45 versus $6.18 expected, and reaffirmed 2026 adjusted EPS guidance of at least $27. Revenue rose 1.4% YoY to $201.11B TTM while earnings fell 13.1%, and quarterly operating income declined sequentially to $2.06B in Q2 from $2.66B in Q1. The company carries $31.04B in total debt (3.7x Debt/EBITDA) against $10.23B in cash, with Q2 free cash flow of $1.63B. Shares are down 4.4% over three months but trade 9.4% above the 200-day SMA, with an analyst target of $451.38.
Valuation
- Market cap
- $85.90B
- P/E
- 17.51
- PEG
- 1.304
- P/B
- 1.926
- P/S
- 0.427
- Beta
- 0.696
- Analyst target
- $451.38
Quality & returns
- Gross margin
- 26.0%
- Operating margin
- 4.6%
- Profit margin
- 2.5%
- ROE
- 11.1%
- ROA
- 3.8%
Price movement
- Last
- $396.09
- 1-month
- -0.3%
- 3-month
- -4.4%
- RSI (14)
- 43
- vs SMA200
- +9.4%
- 52-wk position
- 80.5% -6.8% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $50.47B | $2.06B | $1.46B | $2.10B |
| 2026-03-31 | $50.18B | $2.66B | $1.76B | $2.77B |
| 2025-12-31 | $49.75B | $581.0M | $547.0M | $987.0M |
| 2025-09-30 | $50.71B | $1.76B | $1.19B | $2.14B |
Recent news
- Neutral New analysis points finger at payers for IDR problems · 2026-09-25
- Somewhat-Bullish Elevance Health stock heads into the open after a 0.8 percent gain · 2026-09-25
- Neutral Danaher Corporation (DHR) stock price, news, quote and history - Yahoo Finance · 2026-09-24
- Neutral Five Texas Hospitals Tied to HCA Sue Independence Blue Cross Over $345,000 in Denied Claims, Including Emergency Care · 2026-09-24
- Bullish Elevance Health stock carries a USD 27 adjusted EPS outlook · 2026-09-24
- Neutral AM Best withdraws ratings of Elevance Health's Hawaii captive · 2026-09-24
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)